CD
BEAM icon

Chapin Davis’s Beam Therapeutics BEAM Stock Holding History

Chapin Davis’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+6,000
New +$181K 0.04% 244

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Chapin Davis's BEAM Position: Q2 2026 in Review

Chapin Davis opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 6,000 shares worth $206K. The stake represents 0.04% of the portfolio and ranks #244 among its holdings.

278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Chapin Davis held 6,000 shares of Beam Therapeutics worth $206K as of Q2 2026.
  • Beam Therapeutics was a new Chapin Davis position in Q2 2026.
  • Beam Therapeutics made up 0.04% of Chapin Davis's portfolio in Q2 2026, its #244 holding.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.